A Five-Variable Nomogram Targets Exercise-Induced Respiratory Symptoms in Athletes
Competitive athletes often normalize shortness of breath, cough, or chest tightness during training until symptoms become too persistent to ignore. In that setting, exercise-induced respiratory symptoms can be missed, dismissed, or underreported, especially when cultural pressure rewards endurance and discourages complaint. A new model built from athletes in Chongqing tries to close that gap by turning a brief clinical history into a practical risk estimate.
Investigators surveyed athletes from five centers between December 2021 and December 2022 and used those data to construct and test a predictive model for EIRS. The final tool retained five variables: sex, type of sport, history of allergy, gastroesophageal reflux disease, and allergic rhinitis. It was then displayed as a nomogram, a format that allows clinicians and trainers to translate multiple risk factors into a single estimated probability at the bedside or in a sports medicine clinic.
The central result was straightforward. The model separated athletes with and without EIRS with good discrimination, and internal checks suggested acceptable calibration, meaning predicted risk tracked reasonably well against observed outcomes in the study cohort.
Why Respiratory Symptoms in Sport Are So Easy to Miss
EIRS in athletes sits at the intersection of physiology, performance culture, and symptom reporting behavior. Some athletes attribute wheeze, throat tightness, or exertional breathlessness to conditioning, poor pacing, or temporary fatigue. Others avoid bringing up symptoms because any hint of limitation can feel professionally costly. When asthma, exercise-induced bronchoconstriction, rhinitis, or reflux overlap, the clinical picture becomes even noisier, and a single complaint may hide more than one mechanism.
The five selected variables make biological sense in that context. Allergic rhinitis and a history of allergy point toward an atopic tendency, which can track with airway hyperreactivity. GERD can aggravate cough and upper airway irritation, especially during strenuous activity and mechanical stress on the abdomen and thorax. Sex and sport type likely function as practical proxies for exposure patterns, training demands, and differences in symptom recognition across athletic disciplines.
This is not a diagnostic endpoint in the sense of spirometry or bronchoprovocation testing. It is a pretest risk tool, and that role matters because many sports settings do not have immediate access to respiratory testing. A short questionnaire-based model can help decide who needs closer evaluation rather than waiting for symptoms to declare themselves in a competition or a training block.
Model Performance and Internal Validation
The study included 147 athletes. On bootstrap receiver operating characteristic analysis, the model achieved an AUC of 0.806, with a 95% confidence interval from 0.731 to 0.878. In practical terms, that places the tool in a range that is meaningfully better than chance and strong enough to justify cautious clinical interest, especially for an exploratory model built from a modest cohort.
Calibration analysis supported the accuracy of the predicted probabilities, suggesting the nomogram was not merely ranking risk but estimating it with reasonable alignment to observed outcomes. Ten-fold cross-validation showed moderate internal predictive performance, which is an important check against overfitting in a relatively small sample. Decision curve analysis also suggested clinical utility, indicating that using the model may offer net benefit across relevant threshold probabilities rather than simply looking impressive on statistical paper.
A predictive model can fail in two different ways: it can misclassify who is at risk, or it can produce probabilities that look tidy but do not help real decisions. This one appears to have avoided both extremes within its derivation cohort.
What the Nomogram Can and Cannot Do at the Sideline
The promise of the nomogram is not that it replaces respiratory testing, clinical examination, or longitudinal follow-up. Its value lies in triage. In a sports medicine setting, an athlete with a history of allergy, allergic rhinitis, reflux, and a relevant sport profile may deserve earlier evaluation for EIRS-related pathology than another athlete with isolated exertional dyspnea and no allergic background. That could mean earlier referral for pulmonary assessment, more careful symptom documentation, or a lower threshold for structured questioning about exercise triggers.
Because the cohort came from five centers in Chongqing, the model reflects one clinical and geographic environment. The study design supports internal validity, not broad generalization. Athlete populations differ by age, sex distribution, sport mix, coaching culture, environmental exposure, and access to respiratory diagnostics. Those differences can shift the performance of a prediction tool even when the underlying biology is stable.
The authors explicitly call for external validation in larger and more diverse athlete populations before broader clinical use. That caution is warranted. Prediction models often perform best where they are built, then weaken when moved into new settings with different prevalence, different referral behavior, or different symptom-reporting norms.
A Practical Step Toward Earlier Recognition
Still, the study addresses a real gap. EIRS is common enough to affect training tolerance, performance, and clinical surveillance, yet subtle enough to remain hidden until symptoms interfere with sport. By combining a handful of easily obtained variables into a nomogram, the model offers a workable framework for earlier suspicion. The structure is especially attractive for environments where clinicians need a fast screen before deciding who should undergo more formal respiratory workup.
The underlying clinical message is direct: respiratory symptoms during exercise should not be treated as a vague complaint in elite or competitive sport. In a population where underreporting is common, a small set of risk factors can help surface athletes who might otherwise stay below the threshold for attention.
The next test is external performance, not statistical elegance. Until the model is validated in broader athlete cohorts, its role should remain as a screening aid rather than a stand-alone decision tool.